Herve Hoppenot - 06 Oct 2025 Form 4 Insider Report for Maze Therapeutics, Inc. (MAZE)

Role: Director
Signature: /s/ Courtney Phillips, as attorney-in-fact
Issuer symbol: MAZE
Transactions as of: 06 Oct 2025
Net transactions value: $0
Form type: 4
Filing time: 07 Oct 2025, 16:17:27 UTC
Previous filing: 10 Sep 2025
Next filing: 12 Nov 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Hoppenot Herve	Director	C/O MAZE THERAPEUTICS, INC., 171 OYSTER POINT BOULEVARD, SUITE 300, SOUTH SAN FRANCISCO	/s/ Courtney Phillips, as attorney-in-fact	07 Oct 2025	0001596492

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MAZE	Stock Option (Right to Buy)	Award	$0	+36,000		$0.000000	36,000	06 Oct 2025	Common Stock	36,000	$27.52	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option shall vest as to 1/36th of the total award monthly, with the first tranche vesting on November 6, 2025, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.